NovAliX expands cryo-electron microscopy (cryo-EM) capabilities for drug development offering
Expansion includes acquisition of novel, high-resolution cryo-electron microscope – with micro electron diffraction (mic…
Expansion includes acquisition of novel, high-resolution cryo-electron microscope – with micro electron diffraction (mic…
Founded in 2002 and based in Strasbourg, France, NovAliX is a drug discovery-focused CRO with several unique technologie…
NovAliX SAS announced today that it has entered into a fragment-based drug discovery project with Kyowa Hakko Kirin Co.,…
Inventiva and NovAliX announced today that they have entered into a strategic alliance dedicated to the discovery of cli…
NovAliX SAS announced today that it has entered into a fragment-based drug discovery alliance with Kyowa Hakko Kirin Co.…
NovAliX a company engaged in small molecules drug research with strong capabilities in chemistry and biophysical science…
NovAliX today announces that it has entered into drug discovery collaboration with the pharmaceutical company Servier.…
NovAliX SAS announced today that it has entered into a multi-target integrated drug discovery collaboration with Teijin…
NovAliX today announces that it has entered into a multi-year drug research collaboration in the field of trisomy 21 wit…
NovAliX today announces that it has entered into drug discovery collaboration in the field of osteoarthritis with Galapa…